Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Head & Neck 1Breast 1

Conditions

Breast Neoplasms 29Neoplasms 8Neoplasm Metastasis 8Brain Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Glioma 4Endometrial Neoplasms 4Triple Negative Breast Neoplasms 3Neoplasms by Site 3Breast Diseases 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Meningioma 2Head and Neck Neoplasms 2Glioblastoma 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Neoplasms, Squamous Cell 1Neoplasm, Residual 1Multiple Myeloma 1

Interventions

pembrolizumab 23Paclitaxel 23Carboplatin 15Specimen Handling 13Bevacizumab 12Magnetic Resonance Spectroscopy 10Doxorubicin 8Biopsy 8lenvatinib 7Taxes 7olaparib 6Letrozole 6Fulvestrant 6Cisplatin 6dostarlimab 5Nivolumab 5Gemcitabine 5abemaciclib 4X-Rays 4Trastuzumab 4Oxaliplatin 4Medroxyprogesterone Acetate 4Immunoglobulin G 4Fluorouracil 4Docetaxel 4trastuzumab deruxtecan 3palbociclib 3ipatasertib 3durvalumab 3Tirzepatide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Endometrial Neoplasms × abemaciclib × 90 days × Clear all
NCT05768139 2026-05-22

PIKALO-1

Eli Lilly and Company

Phase 1/2 Recruiting
880 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT07209449 2026-05-22

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
75 enrolled
Gynecologic

Recurrence, Endometrial Neoplasms

NCT04486352 2026-04-01

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting
148 enrolled
Gynecologic

Endometrial Neoplasms

NCT04393285 2026-03-09

Abemaciclib and Letrozole to Treat Endometrial Cancer

GOG Foundation

Phase 2 Active not recruiting
53 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡